New Pharmacokinetic (PK) and Pharmacodynamic Data from Sub-Study in Phase III Trial Strengthens Scientific Basis for RenovoRx ...
New subgroup analysis shows consistent, clinically meaningful pain reduction observed from Stage 2 through Stage 4 disease, including late-stage ...
Healthcare AI is scaling faster than clinical safety. Without clinicians in the loop, companies face growing liability, ...
Michael Wang, MD, highlights several notable abstracts from ASH 2025 that collectively underscore continued progress in ...
Discover how wearable technology, AI diagnostics, and remote monitoring are reshaping heart health for individuals over 40 in ...
3d
Azitra, Inc. to Present at Biotech Showcase Alongside the J.P. Morgan Annual Healthcare Conference
Azitra, Inc. ("Azitra") (NYSE American: AZTR), a clinical stage biopharmaceutical company focused on developing innovative ...
Six of the clinical trials involved semaglutide — the ingredient used in Novo Nordisk's brands Ozempic and Wegovy — and ...
Mental health care faces a paradox: demand has surged to record levels, yet the infrastructure supporting clinicians remains ...
Coya Therapeutics, Inc. (NASDAQ: COYA) (“Coya” or the “Company”), a clinical-stage biotechnology company focused on developing biologics that enhance regulatory T cell (Treg) function in patients with ...
In the 1999 sci-fi classic The Matrix, “plugging in” symbolized digital enslavement. In 2025, for a paraplegia patient in ...
Armed with some data from our friends at CrunchBase, I broke down the largest NYC Startup funding rounds in New York for ...
Q1 2026 Earnings Call Transcript January 8, 2026 Simulations Plus, Inc. misses on earnings expectations. Reported EPS is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback